167 related articles for article (PubMed ID: 6087102)
1. Immobilisation hypercalcemia.
Evans RA; Bridgeman M; Hills E; Dunstan CR
Miner Electrolyte Metab; 1984; 10(4):244-8. PubMed ID: 6087102
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
4. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
[TBL] [Abstract][Full Text] [Related]
7. [Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?].
Gardin JP; Houillier P; Borensztein P; Paillard M
Nephrologie; 1991; 12(2):71-7. PubMed ID: 1944759
[TBL] [Abstract][Full Text] [Related]
8. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
Gardin JP; Paillard M
Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
Bill G; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
[TBL] [Abstract][Full Text] [Related]
10. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.
Stewart AF; Adler M; Byers CM; Segre GV; Broadus AE
N Engl J Med; 1982 May; 306(19):1136-40. PubMed ID: 6280047
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis of primary hyperparathyroidism.
Wade JS
Ann R Coll Surg Engl; 1979 Sep; 61(5):362-5. PubMed ID: 496228
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
Bill G; Jacquet AF; Burckhardt P
Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
[TBL] [Abstract][Full Text] [Related]
13. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
[TBL] [Abstract][Full Text] [Related]
14. Primary hyperparathyroidism in pediatric patients.
Kollars J; Zarroug AE; van Heerden J; Lteif A; Stavlo P; Suarez L; Moir C; Ishitani M; Rodeberg D
Pediatrics; 2005 Apr; 115(4):974-80. PubMed ID: 15805373
[TBL] [Abstract][Full Text] [Related]
15. [Hypercalcemia is the most common manifestation of hyperparathyroidism].
Yuzawa Y; Watanabe Y
Nihon Rinsho; 1995 Apr; 53(4):864-9. PubMed ID: 7752474
[TBL] [Abstract][Full Text] [Related]
16. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
17. Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Fraser WD; Boyle IT
J Bone Miner Res; 1989 Feb; 4(1):103-11. PubMed ID: 2718773
[TBL] [Abstract][Full Text] [Related]
18. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
19. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
20. [Immobilisation hypercalcaemia (author's transl)].
Minaire P; Meunier P; Berard E; Girard R; Bourret J
Nouv Presse Med; 1977 Dec; 6(41):3843-6. PubMed ID: 593868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
